个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues

  作者 ROSEN MARK D; VENKATESAN HARIHARAN; PELTIER HILLARY M; BEMBENEK SCOTT D; KANELAKIS KIMON C; ZHAO LUCY X; LEONARD BARRY E; HOCUTT FRANCES M; WU XIAODONG; PALOMINO HEATHER L; BRONDSTETTER THERESA I; HAUGH PETER V; CAGNON LAURENCE; YAN WEN; LIOTTA LISA A; YOUNG ANDREW; MIRZADEGAN TARA; SHANKLEY NIGEL P; BARRETT TERRANCE D; RABINOWITZ MICHAEL H  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2010年1-9;  页码  526-529  
  关联知识点  
 

[摘要]HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiological responses to hypoxia by modulating the levels of hypoxia inducible factor 1-alpha (HIF1 alpha). Certain benzimidazole-2-pyrazole carboxylates were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内